We have identified a 35 amino acid peptide toxin of the inhibitor cysteine knot family that blocks cationic stretch-activated ion channels. The toxin, denoted GsMTx-4, was isolated from the venom of the spider Grammostola spatulata and has <50% homology to other neuroactive peptides. It was isolated by fractionating whole venom using reverse phase HPLC, and then assaying fractions on stretch-activated channels (SACs) in outside-out patches from adult rat astrocytes. Although the channel gating kinetics were different between cell-attached and outside-out patches, the properties associated with the channel pore, such as selectivity for alkali cations, conductance (∼45 pS at −100 mV) and a mild rectification were unaffected by outside-out formation. GsMTx-4 produced a complete block of SACs in outside-out patches and appeared specific since it had no effect on whole-cell voltage-sensitive currents. The equilibrium dissociation constant of ∼630 nM was calculated from the ratio of association and dissociation rate constants. In hypotonically swollen astrocytes, GsMTx-4 produces ∼40% reduction in swelling-activated whole-cell current. Similarly, in isolated ventricular cells from a rabbit dilated cardiomyopathy model, GsMTx-4 produced a near complete block of the volume-sensitive cation-selective current, but did not affect the anion current. In the myopathic heart cells, where the swell-induced current is tonically active, GsMTx-4 also reduced the cell size. This is the first report of a peptide toxin that specifically blocks stretch-activated currents. The toxin affect on swelling-activated whole-cell currents implicates SACs in volume regulation.
Skip Nav Destination
Article navigation
1 May 2000
Article|
May 01 2000
Identification of a Peptide Toxin from Grammostola spatulata Spider Venom That Blocks Cation-Selective Stretch-Activated Channels
Thomas M. Suchyna,
Thomas M. Suchyna
aFrom the Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, New York 14214
Search for other works by this author on:
Janice H. Johnson,
Janice H. Johnson
bNPS Pharmaceuticals, Inc., Salt Lake City, Utah 84108
Search for other works by this author on:
Katherine Hamer,
Katherine Hamer
bNPS Pharmaceuticals, Inc., Salt Lake City, Utah 84108
Search for other works by this author on:
Joseph F. Leykam,
Joseph F. Leykam
dDepartment of Biochemistry, Michigan State University–National Institutes of Health Mass Spectrometry Facility, Michigan State University, East Lansing, Michigan 48824-1319
Search for other works by this author on:
Douglas A. Gage,
Douglas A. Gage
dDepartment of Biochemistry, Michigan State University–National Institutes of Health Mass Spectrometry Facility, Michigan State University, East Lansing, Michigan 48824-1319
Search for other works by this author on:
Henry F. Clemo,
Henry F. Clemo
cDepartment of Internal Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298
Search for other works by this author on:
Clive M. Baumgarten,
Clive M. Baumgarten
cDepartment of Internal Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298
Search for other works by this author on:
Frederick Sachs
Frederick Sachs
aFrom the Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, New York 14214
Search for other works by this author on:
Thomas M. Suchyna
aFrom the Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, New York 14214
Janice H. Johnson
bNPS Pharmaceuticals, Inc., Salt Lake City, Utah 84108
Katherine Hamer
bNPS Pharmaceuticals, Inc., Salt Lake City, Utah 84108
Joseph F. Leykam
dDepartment of Biochemistry, Michigan State University–National Institutes of Health Mass Spectrometry Facility, Michigan State University, East Lansing, Michigan 48824-1319
Douglas A. Gage
dDepartment of Biochemistry, Michigan State University–National Institutes of Health Mass Spectrometry Facility, Michigan State University, East Lansing, Michigan 48824-1319
Henry F. Clemo
cDepartment of Internal Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298
Clive M. Baumgarten
cDepartment of Internal Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298
Frederick Sachs
aFrom the Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, New York 14214
Abbreviations used in this paper: CHF, congestive heart failure; DIDS, 4,4′-diisothiocyanatostilbene-2,2′-disulphonic acid; ICK, inhibitor cysteine knot; RP, reverse phase; RVD, regulated volume decrease; SAC, stretch-activated channel; TFA, trifluoroacetic acid.
Received:
July 09 1999
Revision Requested:
March 02 2000
Accepted:
March 06 2000
Online ISSN: 1540-7748
Print ISSN: 0022-1295
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Gen Physiol (2000) 115 (5): 583–598.
Article history
Received:
July 09 1999
Revision Requested:
March 02 2000
Accepted:
March 06 2000
Connected Content
This article has been corrected
Correction 115, p.583
Citation
Thomas M. Suchyna, Janice H. Johnson, Katherine Hamer, Joseph F. Leykam, Douglas A. Gage, Henry F. Clemo, Clive M. Baumgarten, Frederick Sachs; Identification of a Peptide Toxin from Grammostola spatulata Spider Venom That Blocks Cation-Selective Stretch-Activated Channels . J Gen Physiol 1 May 2000; 115 (5): 583–598. doi: https://doi.org/10.1085/jgp.115.5.583
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Connected Content
Advertisement